Literature DB >> 1963807

Endothelin and a Ca2+ ionophore raise cyclic GMP levels in a neuronal cell line via formation of nitric oxide.

G Reiser1.   

Abstract

1. The vasoconstrictor peptide endothelin-1 caused a fast, transient rise in guanosine 3':5'-cyclic monophosphate (cyclic GMP) levels in a neuronal cell line (mouse neuroblastoma x rat glioma hybrid cells 108CC15). The mechanism of activation of guanylate cyclase by endothelin-1 was investigated. The endothelin-1-induced rise depended on the release of internal Ca2+. 2. The stimulation of cyclic GMP synthesis induced by endothelin-1 was suppressed after preincubating the cells in medium containing haemoglobin (IC50 3 microM). Similarly, pretreatment of the cells with the L-arginine analogues, L-canavanine (IC50 60 microM) or NG-monomethyl-L-arginine (IC50 2.5 microM), inhibited the cyclic GMP response to endothelin-1. Therefore, endothelin-1 activates guanylate cyclase most probably via formation of nitric oxide, which is released from L-arginine. 3. The Ca2+ ionophore ionomycin induced a transient rise in cyclic GMP levels, which was also suppressed by preincubation in the presence of either haemoglobin or the L-arginine analogues L-canavanine or NG-monomethyl-L-arginine. Therefore, we conclude that ionomycin can activate guanylate cyclase by a mechanism involving nitric oxide formation, similar to that induced by endothelin-1. 4. The alkaloid veratridine, which activates Na+ channels and also causes influx of Ca2+ induced a transient rise of cyclic GMP levels in the neuronal cell line. This stimulation was blocked by pretreating the cells with L-canavanine, NG-monomethyl-L-arginine or haemoglobin. 5. Loading the cells with the Ca2+ chelator BAPTA suppresed the cyclic GMP response to application of endothelin-1, ionomycin, or veratridine. Thus, in the neuronal cell line a rise in cytosolic Ca2 + activity seems to be sufficient to stimulate the nitric oxide forming enzyme which synthesizes the activator of soluble guanylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963807      PMCID: PMC1917739          DOI: 10.1111/j.1476-5381.1990.tb14147.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

Review 1.  Cyclic GMP cascade of vision.

Authors:  L Stryer
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

2.  Culture and characteristics of hormone-responsive neuroblastoma X glioma hybrid cells.

Authors:  B Hamprecht; T Glaser; G Reiser; E Bayer; F Propst
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

Review 3.  The effect of veratridine on excitable membranes of nerve and muscle.

Authors:  W Ulbricht
Journal:  Ergeb Physiol       Date:  1969

4.  Bradykinin receptor-mediated cyclic GMP formation in a nerve cell population (murine neuroblastoma clone N1E-115).

Authors:  R M Snider; E Richelson
Journal:  J Neurochem       Date:  1984-12       Impact factor: 5.372

5.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

6.  Mechanism of stimulation of cyclic-GMP level in a neuronal cell line mediated by serotonin (5-HT3) receptors. Involvement of nitric oxide, arachidonic-acid metabolism and cytosolic Ca2+.

Authors:  G Reiser
Journal:  Eur J Biochem       Date:  1990-05-20

7.  Bradykinin causes a transient rise of intracellular Ca2+-activity in cultured neural cells.

Authors:  G Reiser; B Hamprecht
Journal:  Pflugers Arch       Date:  1985-10       Impact factor: 3.657

8.  Neurotransmitter receptors mediate cyclic GMP formation by involvement of arachidonic acid and lipoxygenase.

Authors:  R M Snider; M McKinney; C Forray; E Richelson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Bradykinin regulates the level of guanosine 3',5'-cyclic monophosphate (cyclic GMP) in neural cell lines.

Authors:  G Reiser; U Walter; B Hamprecht
Journal:  Brain Res       Date:  1984-01-09       Impact factor: 3.252

10.  Identification and characterization of voltage-sensitive calcium channels in neuronal clonal cell lines.

Authors:  S B Freedman; G Dawson; M L Villereal; R J Miller
Journal:  J Neurosci       Date:  1984-06       Impact factor: 6.167

View more
  7 in total

Review 1.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 2.  HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.

Authors:  Pedro Cabrales; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2013-02-12       Impact factor: 8.401

Review 3.  The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention.

Authors:  J A Molina; F J Jiménez-Jiménez; M Ortí-Pareja; J A Navarro
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

4.  Paracrine modulation of androgen synthesis in rat leydig cells by nitric oxide.

Authors:  Ben A Weissman; Enmei Niu; Renshan Ge; Chantal M Sottas; Michael Holmes; James C Hutson; Matthew P Hardy
Journal:  J Androl       Date:  2005 May-Jun

5.  A cyclic GMP-dependent housekeeping Cl- channel in rabbit gastric parietal cells activated by a vasodilator ecabapide.

Authors:  H Sakai; A Ikari; E Kumano; N Takeguchi
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

6.  On the mechanism of M-current inhibition by muscarinic m1 receptors in DNA-transfected rodent neuroblastoma x glioma cells.

Authors:  J Robbins; S J Marsh; D A Brown
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

7.  Role of glutamate NMDA receptors and nitric oxide located within the periaqueductal gray on defensive behaviors in mice confronted by predator.

Authors:  Eduardo F Carvalho-Netto; Karina S Gomes; Vanessa C S Amaral; Ricardo L Nunes-de-Souza
Journal:  Psychopharmacology (Berl)       Date:  2009-02-25       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.